Showing 3011-3020 of 5621 results for "".
- Euclid Vision Announces Official Launch of Cloud-Based Portalhttps://modernod.com/news/euclid-vision-announces-official-launch-of-cloud-based-portal/2480964/Euclid Vision has announced the official rollout of MyEuclid, an interactive, web-based customer portal designed to drive practice efficiency and optimize Euclid Ortho-K fits. The MyEuclid portal was released on a limited basis earlier this year, and the platform is now availa
- Study: AMD Strongly Associated With Heart Disease and Strokehttps://modernod.com/news/study-blinding-eye-disease-is-strongly-associated-with-heart-disease-and-stroke/2480958/Patients with a specific form of age-related macular degeneration (AMD) are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai. This study, published in the July issue of Retina, is the first t
- Glasgow Eye Department Now Using Ocular Simulation Training Through DRV Systemhttps://modernod.com/news/glasgow-eye-department-now-using-ocular-simulation-training-through-drv-system/2480954/Simulation exposure is now an essential component of the Royal College of Ophthalmologists’ Ophthalmic Specialist Training curriculum prior to real-life surgery, according to a news release from Vision Engineering Group, a maker of ergonomic stereo optical and digital instruments. &nbs
- Nicox Announces Publication of NCX 470 Results Demonstrating Improvements to Ocular Hemodynamics and Retinal Cell Physiologyhttps://modernod.com/news/nicox-announces-publication-of-ncx-470-results-demonstrating-improvements-to-ocular-hemodynamics-and-retinal-cell-physiology-1/2480951/Nicox SA announced that the results from studies on the beneficial effects of NCX 470 in a nonclinical model of endothelin-1 (ET-1)-induced ischemia/reperfusion damage of the optic nerve head and retina have been published online in the peer-reviewed Journal of Ocular Pharmacology and Therape
- MeiraGTx Announces Topline Data from the MGT009 Phase 1/2 Clinical Study Demonstrating Safety and Improvement in Vision in XLRP Patientshttps://modernod.com/news/meiragtx-announces-positive-topline-data-from-the-mgt009-phase-12-clinical-study-demonstrating-safety-and-improvement-in-vision-in-xlrp-patients/2480936/MeiraGTx Holdings announced topline data from the phase 1/2 clinical study MGT009 (
- Market Scope: Global PC-IOL Demand Rises Modestly, Soars in a Few Countrieshttps://modernod.com/news/market-scope-global-pc-iol-demand-rises-modestly-soars-in-a-few-countries/2480888/Presbyopia-correcting IOLs experienced steady global growth in 2021 and record-breaking growth in a handful of countries, according to a Market Scope re
- Webinar: Diabetes + Your Eyes: A Conversation Around Patient-Centered Carehttps://modernod.com/news/webinar-diabetes-your-eyes-a-conversation-around-patient-centered-care/2480869/
- Life After Death for the Human Eye: Vision Scientists Revive Light-Sensing Cells in Organ Donor Eyeshttps://modernod.com/news/life-after-death-for-the-human-eye-vision-scientists-revive-light-sensing-cells-in-organ-donor-eyes/2480858/Scientists have revived light-sensing neuron cells in organ donor eyes and restored communication between them as part of a series of discoveries that stand to transform brain and vision research, accor
- Nova Eye Medical Reports Canaloplasty Data Demonstrating Sustained Reduction in IOP with iTrackhttps://modernod.com/news/nova-eye-medical-reports-canaloplasty-data-demonstrating-sustained-reduction-in-iop-with-itrack/2480849/Nova Eye Medical reported the recent publication of three investigator-led, retrospective case series which evaluated the long-term effectiveness of canaloplasty in patients with open-angle glaucoma (OAG) over 36- and 48-month periods, and in post-keratoplasty patients. Performed b
- C. Light Technologies Announces Activities and New Partnerships at ARVOhttps://modernod.com/news/c-light-technologies-announces-activities-and-new-partnerships-at-arvo/2480821/At this year’s Association for Research in Vision and Ophthalmology (ARVO), C. Light Technologies will meet with colleagues at booth #2424 to share engineering and software development updates from their new pipeline instrument,